Shijiazhuang Yiling Pharmaceutical Co Ltd
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfec… Read more
Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.042x
Based on the latest financial reports, Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a cash flow conversion efficiency ratio of 0.042x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥446.51 Million) by net assets (CN¥10.70 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shijiazhuang Yiling Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Shijiazhuang Yiling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shijiazhuang Yiling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shijiazhuang Yiling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Xi an Bright Laser Tech Co Ltd
SHG:688333
|
0.022x |
|
Parq Arauco
SN:PARAUCO
|
0.027x |
|
Auras Technology Co Ltd
TWO:3324
|
-0.072x |
|
Steven Madden Ltd
NASDAQ:SHOO
|
0.006x |
|
DTZNY
OTCQB:DTZNY
|
N/A |
|
Pharmaron Beijing Co., Ltd.
PINK:PHBBF
|
N/A |
|
DSFIY
PINK:DSFIY
|
N/A |
|
Premium Brands Holdings Corporation
PINK:PRBZF
|
0.018x |
Annual Cash Flow Conversion Efficiency for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥10.20 Billion | CN¥611.01 Million | 0.060x | +340.66% |
| 2023-12-31 | CN¥11.44 Billion | CN¥155.46 Million | 0.014x | -95.74% |
| 2022-12-31 | CN¥10.93 Billion | CN¥3.49 Billion | 0.319x | +447.54% |
| 2021-12-31 | CN¥9.07 Billion | CN¥528.69 Million | 0.058x | -67.22% |
| 2020-12-31 | CN¥8.92 Billion | CN¥1.59 Billion | 0.178x | +1950.92% |
| 2019-12-31 | CN¥7.95 Billion | CN¥68.93 Million | 0.009x | -9.41% |
| 2018-12-31 | CN¥7.56 Billion | CN¥72.37 Million | 0.010x | -40.65% |
| 2017-12-31 | CN¥7.11 Billion | CN¥114.65 Million | 0.016x | -86.39% |
| 2016-12-31 | CN¥5.33 Billion | CN¥631.64 Million | 0.118x | +333.58% |
| 2015-12-31 | CN¥4.83 Billion | CN¥131.88 Million | 0.027x | +17.48% |
| 2014-12-31 | CN¥4.55 Billion | CN¥105.90 Million | 0.023x | +79.00% |
| 2013-12-31 | CN¥4.26 Billion | CN¥55.32 Million | 0.013x | -28.77% |
| 2012-12-31 | CN¥3.84 Billion | CN¥70.13 Million | 0.018x | +116.53% |
| 2011-12-31 | CN¥3.70 Billion | CN¥-408.49 Million | -0.110x | -140.17% |
| 2010-12-31 | CN¥1.09 Billion | CN¥299.72 Million | 0.275x | -31.75% |
| 2009-12-31 | CN¥790.55 Million | CN¥318.21 Million | 0.403x | -7.30% |
| 2008-12-31 | CN¥484.03 Million | CN¥210.18 Million | 0.434x | -- |